Wuhan Hiteck Biological Pharma Co.,Ltd.’s Net Profit Dropped 28.8% in First Quarter of 2022

Wuhan Hiteck Biological Pharma Co.,Ltd. (武汉海特生物制药股份有限公司) (300683.SZ) reported a net profit of 10.1 million yuan in the first quarter of 2022, down 28.8% year-on-year.

Meanwhile, the company posted 166.2 million yuan in revenue, up 5.3% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 341.1 million yuan in total liabilities, with a liability-to-asset ratio of 12.7%.